SPAC212.06c Antibody

Shipped with Ice Packs
In Stock

Description

Antibody Identification and Availability

The SPAC212.06c antibody (Product ID: CSB-PA520555XA01SXV) is commercially available as a custom reagent for fission yeast research . Key specifications include:

  • Target organism: Schizosaccharomyces pombe (strain 972/ATCC 24843).

  • Applications: Immunoblotting (WB), immunofluorescence (IF), and chromatin immunoprecipitation (ChIP) .

  • Epitope: Polyclonal antibodies typically recognize linear epitopes of the SPAC212.06c protein, though the exact epitope remains uncharacterized in public databases.

Functional Context in Fission Yeast Research

SPAC212.06c is located in subtelomeric regions of chromosome II in S. pombe, a hotspot for heterochromatin regulation and gene silencing . The antibody has been employed in studies exploring:

  • Heterochromatin maintenance: SPAC212.06c resides near loci where Swi6 (a heterochromatin protein) binding is critical for silencing subtelomeric genes like ura4+ .

  • RNA splicing regulation: In a study of the splicing regulator Sde2, SPAC212.06c was identified as a gene whose expression changes were validated using RT-qPCR and microarray analyses in Δsde2 mutants .

Chromatin Immunoprecipitation (ChIP)

The SPAC212.06c antibody was indirectly implicated in ChIP experiments analyzing Swi6 distribution. In aneuploid strains, Swi6 binding at subtelomeric regions (including SPAC212.06c) was reduced, correlating with gene desilencing . For example:

  • Subtel::ura4+ silencing: Loss of Swi6 binding at SPAC212.06c-associated regions led to ura4+ expression, detectable via 5-FOA sensitivity assays .

Gene Expression Profiling

Microarray data from Δsde2 mutants revealed altered expression of SPAC212.06c, which was confirmed by RT-qPCR . These findings suggest SPAC212.06c may participate in spliceosome-related pathways, though mechanistic details remain under investigation.

Technical Validation

  • Western blot: While direct evidence for SPAC212.06c protein detection is limited, analogous studies in S. pombe use HA-tagged proteins and anti-HA antibodies (e.g., 3F10) for immunoblotting .

  • Specificity: Custom antibodies like SPAC212.06c require validation via knockout strains or epitope-tagged constructs, though such data are not publicly available for this antibody.

Future Directions

Further studies could explore:

  • Protein-protein interactions: Co-IP assays to identify binding partners of SPAC212.06c.

  • Localization: Subcellular tracking using immunofluorescence.

  • Functional knockout analysis: Phenotypic characterization of SPAC212.06cΔ strains.

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
SPAC212.06c antibody; RecQ DNA helicase-like protein C212.06c antibody
Target Names
SPAC212.06c
Uniprot No.

Target Background

Function
The antibody targets a truncated ATP-dependent 3' to 5' DNA helicase.
Database Links
Protein Families
Helicase family, RecQ subfamily

Q&A

What is SPAC212.06c and what are the applications of antibodies targeting it?

SPAC212.06c is a gene found in Schizosaccharomyces pombe (fission yeast) that appears to be located in the subtelomeric region of chromosome 1. Based on genomic data from S. pombe, SPAC212 genes are positioned within heterochromatic regions that are typically bound by heterochromatin protein Swi6 . Antibodies targeting the protein encoded by SPAC212.06c are valuable tools for investigating chromatin organization, particularly in relation to heterochromatin formation and maintenance in fission yeast. These antibodies can be used in chromatin immunoprecipitation (ChIP), immunofluorescence microscopy, and western blotting to study protein localization, interactions, and dynamics within the cell.

How should researchers validate the specificity of SPAC212.06c antibodies?

Antibody validation is critical for ensuring reliable experimental results. For SPAC212.06c antibodies, researchers should:

  • Perform western blotting against wild-type cells and a deletion mutant (if viable) or a strain with epitope-tagged SPAC212.06c.

  • Conduct immunoprecipitation followed by mass spectrometry to confirm target binding.

  • Test cross-reactivity with related proteins, particularly those in the SPAC212 family.

  • Validate antibody performance in intended applications (ChIP, immunofluorescence, etc.).

  • Include appropriate negative controls in experiments, such as pre-immune serum or IgG controls.

Cross-validation using multiple techniques is essential, as heterochromatin proteins can present specificity challenges due to shared domains and structural similarities.

What controls are essential when using SPAC212.06c antibodies in ChIP experiments?

When using SPAC212.06c antibodies in ChIP experiments, researchers should include the following controls:

Control TypePurposeImplementation
Input DNANormalize for DNA abundance and sequence biasReserve 5-10% of pre-immunoprecipitated chromatin
No-antibody controlAssess non-specific binding to beadsPerform IP procedure without antibody
IgG controlMeasure background from random antibody bindingUse same species IgG at equivalent concentration
Positive control lociConfirm ChIP efficacyTarget known binding regions (if available)
Negative control lociEstablish background signalTarget regions where protein shouldn't bind
Deletion strain controlVerify antibody specificityPerform ChIP in SPAC212.06c deletion strain (if viable)

These controls are particularly important when studying telomeric or subtelomeric regions where SPAC212.06c may be expressed, as demonstrated by studies on neighboring genes such as SPAC212.10 and SPAC212.09c .

How can researchers optimize ChIP-seq protocols for studying SPAC212.06c in heterochromatic regions?

Optimizing ChIP-seq for SPAC212.06c in heterochromatic regions requires addressing several challenges unique to compact chromatin structures:

  • Chromatin fragmentation optimization: Heterochromatin is typically resistant to standard sonication methods. Researchers should consider using a micrococcal nuclease (MNase) digestion approach as described in previous studies , optimizing digestion time to achieve fragments of 150-300 bp for adequate resolution.

  • Crosslinking modification: Extend formaldehyde crosslinking time to 30 minutes at 18°C as used in successful S. pombe ChIP protocols , which improves capture of proteins in heterochromatin regions.

  • Antibody selection: Use high-affinity antibodies with validated specificity for the target protein, as heterochromatic regions have lower accessibility.

  • Sequencing depth increases: Heterochromatic regions often require greater sequencing depth due to repetitive sequences. Aim for a minimum of 20 million uniquely mapped reads.

  • Bioinformatics accommodation: Apply specialized alignment algorithms capable of handling repetitive sequences typical in telomeric and subtelomeric regions where SPAC212 genes reside .

When analyzing data, it's important to compare the binding patterns with known heterochromatin markers such as Swi6, which has been well-documented to bind subtelomeric regions extending approximately 50-90 kb from chromosome ends in wild-type S. pombe .

What are the challenges in interpreting ChIP data for SPAC212.06c in the context of heterochromatin spreading?

Interpreting ChIP data for SPAC212.06c in heterochromatin contexts presents several challenges:

  • Discriminating direct from indirect binding: As heterochromatin consists of protein complexes with multiple interactions, determining if SPAC212.06c directly binds DNA or is recruited through interactions with other proteins (such as Swi6) requires careful experimental design.

  • Resolving spreading phenomena: Heterochromatin spreading, as observed with FACT mutants affecting Pob3 and Spt16, complicates the interpretation of binding data . Researchers should consider using assays like the heterochromatin spreading suppression (HSS) assay to differentiate between nucleation and spreading effects .

  • Accounting for heterochromatin state variations: Heterochromatin states can vary with temperature, cellular conditions, and genetic background. For example, silencing increases at lower temperatures in S. pombe , potentially affecting SPAC212.06c localization or function.

  • Distinguishing specific binding from technical artifacts: Subtelomeric regions contain repetitive sequences that can produce mapping artifacts. Re-analyzing data with multiple alignment strategies and using spike-in controls can help address this issue.

  • Correlating with functional outcomes: Binding patterns should be correlated with gene expression data, particularly for nearby genes, to establish functional relevance. Studies have shown that genes near telomeric regions can show altered expression in aneuploid strains with changes in Swi6 binding .

How does temperature affect experiments involving SPAC212.06c antibodies in heterochromatin studies?

Temperature significantly affects heterochromatin structure and function in S. pombe, which has important implications for experiments using SPAC212.06c antibodies:

  • Temperature effects on heterochromatin stability: Heterochromatin spreading is temperature-sensitive in S. pombe, with increased silencing observed at lower temperatures . When designing experiments involving SPAC212.06c antibodies, researchers should maintain consistent temperature conditions, as variations can lead to different heterochromatin states.

  • Temperature-sensitive mutant considerations: When using temperature-sensitive mutants like spt16-1 (which affects FACT function) in conjunction with SPAC212.06c antibodies, researchers must be aware that even at permissive temperatures (e.g., 27°C), partial loss of function can occur, affecting protein levels and chromatin association .

  • ChIP protocol adaptations: Temperature affects crosslinking efficiency and antibody binding kinetics. For ChIP experiments using SPAC212.06c antibodies, researchers typically perform formaldehyde fixation at 18°C for 30 minutes , which provides optimal crosslinking while preserving chromatin structure.

  • Western blot optimization: For western blot applications, extraction of proteins from heterochromatic regions may require modified protocols depending on the temperature at which cells were grown, as heterochromatin compaction varies with temperature.

  • Immunofluorescence considerations: For immunofluorescence microscopy, the temperature during fixation and antibody incubation should be optimized and standardized, as temperature affects nuclear organization and potentially epitope accessibility.

What are the recommended protocols for extracting proteins from heterochromatic regions for SPAC212.06c antibody validation?

Extracting proteins from heterochromatic regions for antibody validation requires specialized approaches:

  • Enhanced cell disruption: Use a combination of mechanical disruption (glass beads) and enzymatic treatment. For S. pombe, disruption in buffer containing 8M urea helps solubilize heterochromatic proteins.

  • Chromatin fractionation: To enrich for chromatin-bound proteins:

    • Lyse cells in hypotonic buffer

    • Isolate nuclei through differential centrifugation

    • Treat with DNase I to release tightly bound proteins

    • Extract with increasing salt concentrations (0.3M to 2M NaCl)

  • Histone extraction optimization: For proteins associated with histones, use acid extraction (0.4N H₂SO₄) followed by TCA precipitation to obtain histone-associated proteins.

  • Denaturing conditions: Include strong detergents (1-2% SDS) and reducing agents (DTT) in extraction buffers to disrupt protein-protein interactions in heterochromatin.

  • Protease inhibitor enhancement: Use comprehensive protease inhibitor cocktails containing additional inhibitors specific for nuclear proteases.

These methods have proven effective in extracting heterochromatin proteins such as Swi6 from S. pombe for antibody validation purposes .

How can researchers distinguish between SPAC212.06c and other similar proteins in the subtelomeric regions?

Distinguishing between SPAC212.06c and related proteins in subtelomeric regions requires multiple complementary approaches:

  • Epitope mapping: Identify unique epitopes in SPAC212.06c not present in related proteins for antibody production, focusing on regions with low sequence homology.

  • Genetic tagging strategies: Create strains with epitope-tagged versions of SPAC212.06c and related proteins to validate antibody specificity against each protein individually.

  • Mass spectrometry validation: Following immunoprecipitation with the SPAC212.06c antibody, perform mass spectrometry to identify all captured proteins and quantify specificity.

  • Knockout controls: Generate deletion strains for SPAC212.06c and related genes to test antibody cross-reactivity in western blots and ChIP experiments.

  • Competitive binding assays: Pre-incubate antibodies with recombinant proteins or peptides corresponding to unique regions of SPAC212.06c to block specific binding sites.

  • Differential expression analysis: Exploit conditions where SPAC212.06c is differentially expressed compared to related proteins to verify antibody specificity.

Research on similar subtelomeric genes like SPAC212.10 and SPAC212.09c has demonstrated that expression levels can vary significantly in different genetic backgrounds, such as in aneuploid strains, providing opportunities to validate antibody specificity under different conditions .

What approaches are recommended for studying SPAC212.06c interactions with heterochromatin proteins like Swi6?

To investigate interactions between SPAC212.06c and heterochromatin proteins such as Swi6, researchers should consider these methodological approaches:

  • Co-immunoprecipitation (Co-IP): Use SPAC212.06c antibodies to precipitate the protein complex and probe for Swi6 or other heterochromatin proteins. This can be performed with or without crosslinking, with crosslinked samples better preserving weak or transient interactions.

  • Proximity ligation assay (PLA): This technique allows visualization of protein-protein interactions in situ with high sensitivity, using antibodies against both SPAC212.06c and Swi6.

  • ChIP-reChIP: Perform sequential ChIP first with anti-SPAC212.06c antibodies followed by anti-Swi6 antibodies to identify genomic regions where both proteins co-localize.

  • Bimolecular fluorescence complementation (BiFC): Create fusion constructs of SPAC212.06c and Swi6 with split fluorescent protein fragments to visualize interactions in living cells.

  • Genetic interaction studies: Create double mutants (SPAC212.06c with Swi6 or other heterochromatin components) to assess functional relationships through synthetic phenotypes.

Researchers studying heterochromatin proteins in S. pombe have successfully used ChIP combined with DNA microarray to analyze the distribution of proteins like Swi6 in subtelomeric regions . This approach has revealed that Swi6 typically binds to sequences extending approximately 50-70 kb from chromosome ends in wild-type cells, but this binding pattern can be altered in mutant backgrounds.

How should researchers design experiments to study SPAC212.06c function in heterochromatin formation and maintenance?

Designing experiments to investigate SPAC212.06c function in heterochromatin requires a comprehensive approach:

  • Establish phenotypic readouts:

    • Implement silencing assays using reporter genes inserted at heterochromatic loci

    • Develop heterochromatin spreading suppression (HSS) assays similar to those used for FACT components

    • Monitor subtelomeric gene expression changes through RT-qPCR

  • Create and characterize mutant strains:

    • Generate SPAC212.06c deletion strains if viable

    • Create temperature-sensitive alleles for essential functions

    • Develop degron-tagged versions for conditional depletion

    • Engineer point mutations in functional domains

  • Map genome-wide localization:

    • Perform ChIP-seq with SPAC212.06c antibodies under various conditions

    • Analyze co-localization with known heterochromatin marks (H3K9me2/3, Swi6)

    • Compare binding patterns in wild-type and mutant backgrounds

  • Assess chromatin structure impacts:

    • Implement micrococcal nuclease (MNase) digestion assays to examine nucleosome positioning

    • Measure histone modification levels at target loci

    • Evaluate heterochromatin protein recruitment in SPAC212.06c mutants

  • Investigate functional interactions:

    • Perform genetic suppressor screens similar to those used for FACT mutants

    • Create double mutants with known heterochromatin regulators (e.g., SPAC212.06c with epe1Δ)

    • Test for synthetic phenotypes that reveal pathway relationships

These approaches have proven effective in characterizing heterochromatin factors in S. pombe, as demonstrated by studies of FACT components Pob3 and Spt16, which revealed specific roles in heterochromatin spreading .

What experimental strategies can resolve contradictory data when studying SPAC212.06c in different genetic backgrounds?

When faced with contradictory data regarding SPAC212.06c function across different genetic backgrounds, researchers should implement these resolution strategies:

  • Systematic genetic background control:

    • Create isogenic strains differing only in the gene of interest

    • Use backcrossing (minimum 3-5 rounds) to homogenize genetic backgrounds

    • Perform whole-genome sequencing to identify potential secondary mutations

  • Multiple methodological approaches:

    • Employ orthogonal techniques to measure the same phenotype

    • Utilize both genetic and biochemical approaches to study function

    • Implement in vivo and in vitro systems to validate findings

  • Dosage sensitivity analysis:

    • Test SPAC212.06c function at different expression levels

    • Create heterozygous diploids to assess haploinsufficiency

    • Develop overexpression systems to identify dominant effects

  • Condition-dependent phenotyping:

    • Evaluate phenotypes under various environmental conditions (temperature, nutrients)

    • Test cell-cycle specific effects through synchronization experiments

    • Assess stress response contributions through targeted challenges

  • Epistasis analysis framework:

    • Establish genetic hierarchies through double mutant analysis

    • Create an epistasis map of interactions with known heterochromatin pathways

    • Compare suppression patterns with those observed for other factors like FACT components

Studies of gene expression in partial aneuploids of S. pombe have demonstrated that genetic background significantly affects expression patterns of subtelomeric genes, with corresponding changes in heterochromatin protein distribution . This highlights the importance of controlling genetic background when studying genes in these regions.

What are common challenges with SPAC212.06c antibodies in ChIP experiments and how can they be addressed?

Researchers frequently encounter these challenges when using SPAC212.06c antibodies in ChIP experiments:

  • Low signal-to-noise ratio:

    • Increase antibody specificity through affinity purification

    • Optimize crosslinking conditions (time, temperature, formaldehyde concentration)

    • Implement more stringent washing steps (higher salt concentrations)

    • Increase sample input while maintaining antibody excess

  • Inconsistent enrichment:

    • Standardize cell growth conditions and harvesting procedures

    • Verify chromatin fragmentation consistency through gel electrophoresis

    • Implement spike-in controls for normalization

    • Use quantitative PCR to validate enrichment before sequencing

  • Background in heterochromatic regions:

    • Implement blocking strategies with non-specific DNA (salmon sperm DNA)

    • Pre-clear chromatin with protein A/G beads before antibody addition

    • Include additional negative controls targeting unrelated loci

    • Use ChIP-exo or ChIP-nexus for improved resolution

  • Antibody batch variation:

    • Test and validate each new antibody lot

    • Create a standardized positive control sample for batch testing

    • Consider developing monoclonal antibodies for long-term consistency

    • Store working aliquots to reduce freeze-thaw cycles

  • PCR amplification bias:

    • Minimize PCR cycles in library preparation

    • Use high-fidelity polymerases optimized for GC-rich templates

    • Implement PCR-free library preparation methods when possible

    • Verify library quality through bioanalyzer analysis

These troubleshooting approaches have been effective in ChIP experiments studying heterochromatin proteins in S. pombe, including successful mapping of Swi6 distribution across subtelomeric regions and centromeres .

How can researchers address potential artifacts in SPAC212.06c localization studies related to fixation conditions?

Fixation conditions can significantly influence the observed localization of heterochromatin proteins, potentially creating artifacts. Researchers can address these issues through:

  • Fixation optimization matrix:

    • Test multiple formaldehyde concentrations (1-3%)

    • Vary fixation times (10-45 minutes)

    • Compare different temperatures (4°C, 18°C, room temperature)

    • Evaluate alternative fixatives (e.g., DSP, EGS) for protein-protein interactions

  • Validation through live-cell imaging:

    • Create fluorescent protein fusions to validate fixed-cell observations

    • Implement single-particle tracking to assess dynamics

    • Use photobleaching techniques (FRAP) to measure protein turnover

    • Compare results from fixed and live cells systematically

  • Epitope masking assessment:

    • Test multiple antibodies recognizing different epitopes

    • Implement antigen retrieval techniques when appropriate

    • Evaluate the impact of different permeabilization methods

    • Compare native versus denatured immunoprecipitation results

  • Cross-validation with biochemical fractionation:

    • Perform subcellular fractionation to isolate chromatin

    • Use salt extraction series to assess binding strength

    • Compare protein distribution in fractionated versus in situ samples

    • Implement density gradient separation to isolate heterochromatin

  • Systematic controls implementation:

    • Include unfixed controls where possible

    • Process samples with reversed order of antibody addition

    • Test pre-absorption of antibodies with recombinant target

    • Include spike-in controls from different species

For S. pombe heterochromatin studies, researchers have successfully used formaldehyde fixation at 18°C for 30 minutes, followed by glycine quenching and PBS washing, as demonstrated in ChIP experiments investigating Swi6 distribution .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.